Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
52
QGEN Quote, Financials, Valuation and Earnings
Last price:
$45.61
Seasonality move
:
7.55%
Day range:
$45.60 - $46.17
52-week range:
$37.63 - $51.88
Dividend yield:
0.55%
P/E ratio:
24.60x
P/S ratio:
4.82x
P/B ratio:
2.71x
Volume:
1M
Avg. volume:
1.2M
1-year change:
-1.06%
Market cap:
$9.9B
Revenue:
$2B
EPS (TTM):
$1.85
Analysts' Opinion
-
Consensus RatingQIAGEN NV has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $50.57, QIAGEN NV has an estimated upside of 10.88% from its current price of $45.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $45.61.
Fair Value
-
According to the consensus of 13 analysts, QIAGEN NV has 10.88% upside to fair value with a price target of $50.57 per share.
QGEN vs. S&P 500
-
Over the past 5 trading days, QIAGEN NV has underperformed the S&P 500 by -0.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
QIAGEN NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
QIAGEN NV has grown year-over-year revenues for 6 quarters straight. In the most recent quarter QIAGEN NV reported revenues of $532.6M.
Earnings Growth
-
QIAGEN NV has grown year-over-year earnings for 3 quarters straight. In the most recent quarter QIAGEN NV reported earnings per share of $0.60.
Enterprise value:
10.3B
EV / Invested capital:
1.79x
Price / LTM sales:
4.82x
EV / EBIT:
18.98x
EV / Revenue:
4.99x
PEG ratio (5yr expected):
0.07x
EV / Free cash flow:
21.86x
Price / Operating cash flow:
21.11x
Enterprise value / EBITDA:
14.07x
Gross Profit (TTM):
$1.3B
Return On Assets:
6.78%
Net Income Margin (TTM):
19.58%
Return On Equity:
11.48%
Return On Invested Capital:
7.77%
Operating Margin:
25.78%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2B | $2B | $2.1B | $501.9M | $532.6M | |
| Gross Profit | $1.2B | $1.2B | $1.3B | $314.5M | $329.1M | |
| Operating Income | $436.4M | $472M | $544.2M | $129.4M | $137.3M | |
| EBITDA | $644.8M | $681.3M | $734.1M | $179.4M | $188.3M | |
| Diluted EPS | $1.49 | $0.40 | $1.85 | $0.44 | $0.60 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $2.8B | $2B | $2.5B | $2.5B | |
| Total Assets | $6B | $6.5B | $5.9B | $6.3B | $6.6B | |
| Current Liabilities | $1.1B | $1.5B | $524.4M | $1.1B | $973.4M | |
| Total Liabilities | $3B | $3.2B | $2.2B | $2.7B | $2.9B | |
| Total Equity | $3B | $3.3B | $3.7B | $3.5B | $3.6B | |
| Total Debt | $1.9B | $2.3B | $1.5B | $1.9B | $2.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $432.4M | $633.4M | $657.7M | $182.3M | $165M | |
| Cash From Investing | -$153.7M | -$300.9M | -$85.6M | -$231M | -$156.9M | |
| Cash From Financing | -$972.8M | $58.6M | -$189.6M | $485.6M | $614.1M | |
| Free Cash Flow | $275.2M | $459.6M | $472.5M | $138M | $114.6M | |
QGEN
Sector
Market Cap
$9.9B
$28.4M
Price % of 52-Week High
87.92%
51.17%
Dividend Yield
0.55%
0%
Shareholder Yield
4.77%
-1.49%
1-Year Price Total Return
-1.06%
-16.67%
Beta (5-Year)
0.680
0.518
Dividend yield:
0.55%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$45.39
200-day SMA
Buy
Level
$45.44
Bollinger Bands (100)
Sell
Level
44.97 - 48.39
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Sell
Level
$46.26
Relative Strength Index (RSI14)
Sell
Level
47.70
ADX Line
Buy
Level
30.96
Williams %R
Neutral
Level
-62.963
50-day SMA
Sell
Level
$46.24
MACD (12, 26)
Buy
Level
11.25
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
2.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.3343)
Buy
CA Score
(Annual)
Level (0.6168)
Buy
Beneish M-Score
(Annual)
Level (-3.053)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (0.1472)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Stock Forecast FAQ
In the current month, QGEN has received 3 Buy ratings 10 Hold ratings, and 0 Sell ratings. The QGEN average analyst price target in the past 3 months is $50.57.
-
Where Will QIAGEN NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that QIAGEN NV share price will rise to $50.57 per share over the next 12 months.
-
What Do Analysts Say About QIAGEN NV?
Analysts are divided on their view about QIAGEN NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that QIAGEN NV is a Sell and believe this share price will drop from its current level to $45.00.
-
What Is QIAGEN NV's Price Target?
The price target for QIAGEN NV over the next 1-year time period is forecast to be $50.57 according to 13 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is QGEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for QIAGEN NV is a Hold. 10 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of QGEN?
You can purchase shares of QIAGEN NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase QIAGEN NV shares.
-
What Is The QIAGEN NV Share Price Today?
QIAGEN NV was last trading at $45.61 per share. This represents the most recent stock quote for QIAGEN NV. Yesterday, QIAGEN NV closed at $45.61 per share.
-
How To Buy QIAGEN NV Stock Online?
In order to purchase QIAGEN NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get QGEN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
QGEN
Sector
P/E ratio
24.60x
23.89x
PEG ratio
0.07x
-0.01x
P/B ratio
2.71x
1.81x
Price / LTM sales
4.82x
1.58x
Growth Metrics
QGEN
Sector
Revenue growth
6.12%
4.62%
Earnings growth
36.01%
10.7%
Revenue (5-year growth)
5.32%
6.5%
Earnings forecast
$0.59
-$0.21
Profitability
QGEN
Sector
Profitability FY 2024
$1.3B
$3.6M
Return on invested capital
7.77%
-31.84%
Return on assets
6.78%
-27.96%
Return on equity
11.48%
-37.63%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
3
Balance Sheet
QGEN
Sector
Total cash
$1.7B
$26.4M
Short term investments
$489.4M
$25.7M
Total assets
$5.7B
$76.9M
Long term debt
$2.1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
